NMN

DIETARY_SUPPLEMENT5 trials

Sponsors

EffePharm LTD, Shanghai Cell Therapy Group Co.,Ltd, Peking University Third Hospital, People's Hospital of Quzhou, Qing Su

Conditions

AgingDiminished Ovarian ReserveEnhance Immune FunctionImmunosenescenceMetabolismNMN

Early Phase 1

The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.

Shanghai Cell Therapy Group Co.,LtdEnhance Immune Function

Start: 2023-08-31End: 2024-12-31Target: 10Updated: 2023-08-21

Unknown Phase

Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3)

CompletedNCT04228640

EffePharm LTDAging

Start: 2020-12-15End: 2021-03-30Updated: 2021-04-01

The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR

RecruitingNCT06426355

Peking University Third HospitalDiminished Ovarian Reserve

Start: 2023-10-01End: 2027-02-28Target: 200Updated: 2024-05-23

Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People

RecruitingNCT06592859

People's Hospital of QuzhouAging, NMN

Start: 2023-08-23End: 2026-12-31Target: 240Updated: 2026-05-08

The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.

RecruitingNCT06907329

Qing SuImmunosenescence, Metabolism

Start: 2025-06-05End: 2027-03-31Target: 126Updated: 2025-07-08

Related Papers

A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults

Frontiers in Aging2022-05-0553 citations